相似文献
1
Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents.
Infect Drug Resist. 2019 Apr 2;12:759-762. doi: 10.2147/IDR.S184598. eCollection 2019.
2
Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents.
Clin Gastroenterol Hepatol. 2016 Nov;14(11):1662-1666.e1. doi: 10.1016/j.cgh.2016.05.016. Epub 2016 May 20.
3
Herpes Zoster reactivation in patients with chronic hepatitis C under treatment with directly acting antiviral agents: A case series.
Arab J Gastroenterol. 2017 Mar;18(1):39-41. doi: 10.1016/j.ajg.2017.02.003. Epub 2017 Mar 18.
4
Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
BMC Infect Dis. 2017 Mar 1;17(1):182. doi: 10.1186/s12879-017-2287-y.
5
No Association Between DAA Treatment for HCV Infection and Herpes Zoster Infection in Analysis of Data From 37 Clinical Trials.
Clin Gastroenterol Hepatol. 2021 Aug;19(8):1670-1678. doi: 10.1016/j.cgh.2020.08.042. Epub 2020 Aug 21.
6
Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy.
J Viral Hepat. 2018 May;25(5):608-611. doi: 10.1111/jvh.12840. Epub 2017 Dec 28.
7
Risk of Hepatitis B Virus Reactivation Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.
J Clin Gastroenterol. 2018 Nov/Dec;52(10):908-912. doi: 10.1097/MCG.0000000000000986.
8
High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective.
J Antimicrob Chemother. 2016 Sep;71(9):2642-5. doi: 10.1093/jac/dkw203. Epub 2016 Jun 20.
9
A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?
Clin J Gastroenterol. 2016 Aug;9(4):252-6. doi: 10.1007/s12328-016-0657-4. Epub 2016 Jun 21.
10
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Gastroenterology. 2017 Jun;152(8):2052-2062.e2. doi: 10.1053/j.gastro.2017.02.037. Epub 2017 Mar 6.
引用本文的文献
1
The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C Infection.
Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1365-1372. doi: 10.31557/APJCP.2022.23.4.1365.
2
Treg cells in the course of chronic hepatitis C virus infection partially normalize in longitudinal observation after successful DAA treatment regardless of hepatic fibrosis stage.
Clin Exp Hepatol. 2021 Jun;7(2):196-204. doi: 10.5114/ceh.2021.107122. Epub 2021 Jun 30.
3
Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant -Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein.
Int J Mol Sci. 2021 Jun 26;22(13):6892. doi: 10.3390/ijms22136892.
本文引用的文献
1
Herpes Zoster reactivation in patients with chronic hepatitis C under treatment with directly acting antiviral agents: A case series.
Arab J Gastroenterol. 2017 Mar;18(1):39-41. doi: 10.1016/j.ajg.2017.02.003. Epub 2017 Mar 18.
2
Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents.
Clin Gastroenterol Hepatol. 2016 Nov;14(11):1662-1666.e1. doi: 10.1016/j.cgh.2016.05.016. Epub 2016 May 20.
3
Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis.
BMC Infect Dis. 2015 Jul 24;15:285. doi: 10.1186/s12879-015-1038-1.
4
A glass half full: Implications of screening for hepatitis C virus in the era of highly effective antiviral therapy.
Hepatology. 2015 May;61(5):1455-8. doi: 10.1002/hep.27718. Epub 2015 Mar 20.
5
The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis.
J Hepatol. 2015 Feb;62(2):311-6. doi: 10.1016/j.jhep.2014.09.025. Epub 2014 Oct 2.
6
EASL Clinical Practice Guidelines: management of hepatitis C virus infection.
J Hepatol. 2014 Feb;60(2):392-420. doi: 10.1016/j.jhep.2013.11.003. Epub 2013 Dec 9.
7
Herpesviruses: latency and reactivation - viral strategies and host response.
J Oral Microbiol. 2013 Oct 25;5:22766. doi: 10.3402/jom.v5i0.22766.
8
Immune reconstitution inflammatory syndrome after highly active antiretroviral therapy: a review.
Oral Dis. 2010 Apr;16(3):248-56. doi: 10.1111/j.1601-0825.2009.01628.x. Epub 2009 Sep 16.
9
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.
J Hepatol. 2009 Apr;50(4):719-28. doi: 10.1016/j.jhep.2008.11.015. Epub 2008 Dec 29.
10
Non-invasive evaluation of liver fibrosis using transient elastography.
J Hepatol. 2008 May;48(5):835-47. doi: 10.1016/j.jhep.2008.02.008. Epub 2008 Feb 26.
Zotero 插件